Interestingly, four of them, ERBB2 (HER2/neu), MIEN1, PGAP3, and STARD3, mapped to 17q12, a region frequently amplified in breast cancer (Figure S8 in Supplementary Presentation S1 in Supplementary Material). Here, STARD3 is linked to breast cancer.